BioInsights - Vol 7 Issue 12

CELL & GENE THERAPY INSIGHTS

Vol 7 Issue 12

Cell & Gene Therapy Vol 7 Issue 12

Download PDF

Featuring

Issue Spotlight: Tools of tomorrow
Starting material collection & optimization
Other articles

Tools of tomorrow

Innovator Insight

Accelerating gene therapy development: from concept to clinic

Accelerating gene therapy development: from concept to clinic

S Gill, Q Lui, R Cawood

20 January 2022

Success strategies for cell and gene therapy 3.0

Success strategies for cell and gene therapy 3.0

Joe DePinto, Richard Gaeto

14 December 2021

Interview

Driving development and commercialization of iPSCderived allogeneic T cell therapies

Driving development and commercialization of iPSCderived allogeneic T cell therapies

31 January 2022

Unlocking barriers to further gene therapy success in eye disease

Unlocking barriers to further gene therapy success in eye disease

Jed Chatterton

Innovation in rAAV gene therapy is a need: AAV capsids

Innovation in rAAV gene therapy is a need: AAV capsids

Lester Suarez

16 December 2021

FastFacts

Biacore™ systems for viral vector titer analysis

Biacore™ systems for viral vector titer analysis

Anna Moberg

Rapid Quantitation of Viral Vectors with Simple Plex Microfluidic Immunoassays

Rapid Quantitation of Viral Vectors with Simple Plex Microfluidic Immunoassays

Nathan Steere

20 December 2021

Process development and scale-up of pluripotent stem cell manufacturing

Process development and scale-up of pluripotent stem cell manufacturing

Gary M Pigeau PhD

16 December 2021

Viewpoint

Process analytical technology tools for process monitoring in CGT product manufacturing

Process analytical technology tools for process monitoring in CGT product manufacturing

Wai Lam W Ling, Arun C Patel

18 January 2022

Starting material collection & optimization

Expert Insight

Umbilical cord blood NK cells offer multiple advantages for cancer immunotherapy: lessons learned from Glycostem’s orphan drug oNKord®

Umbilical cord blood NK cells offer multiple advantages for cancer immunotherapy: lessons learned from Glycostem’s orphan drug oNKord®

Volker Huppert

14 January 2022

Navigating regulations to provide ethically sourced cellular material for research and development: UK perspective

Navigating regulations to provide ethically sourced cellular material for research and development: UK perspective

Salmah Ahmed

11 January 2022

Interview

Pandemic-related trends and challenges in adult donor stem cell and cord blood collection, banking, and processing

Pandemic-related trends and challenges in adult donor stem cell and cord blood collection, banking, and processing

Heidi Elmoazzen, PhD

11 January 2022

Innovator Insight

Considerations for developing scalable and efficient collection network processes

Considerations for developing scalable and efficient collection network processes

L Anderson, S Butler, A Montalvo

11 January 2022

Journal articles

Editorial

Cell and gene therapy approvals soar in the first half of 2021

Cell and gene therapy approvals soar in the first half of 2021

Christopher A Bravery

20 December 2021

Perspective

Demonstrating Comparability of AAV Gene Therapy Products During Clinical Development: Managing the Link Between the Product and the Process

Demonstrating Comparability of AAV Gene Therapy Products During Clinical Development: Managing the Link Between the Product and the Process

Niamh Kinsella, Clare Blue

16 December 2021

Innovator Insight

Accelerating analytical testing for GMP plasmid production

Accelerating analytical testing for GMP plasmid production

20 January 2022

Achieving high non-viral transfection performance for cell therapy processing

Achieving high non-viral transfection performance for cell therapy processing

N Andronikou, J Fraietta, T Roth

27 January 2022

Automating the final cell therapy bioprocess step for robust CMC/GMP compliance

Automating the final cell therapy bioprocess step for robust CMC/GMP compliance

Tracy Moore, Delara Motlagh

7 February 2022

Interview

US FDA perspective: getting back into high gear – driving cell and gene therapy forward through 2022 and beyond

US FDA perspective: getting back into high gear – driving cell and gene therapy forward through 2022 and beyond

Peter Marks

20 December 2021

Therapeutic potential of extracellular vesicles

Therapeutic potential of extracellular vesicles

A Kauffman, P Chiang, L Hsu et al.

24 January 2022

FastFacts

Stable lentiviral vector producer cell line for a scalable manufacture

Stable lentiviral vector producer cell line for a scalable manufacture

2 December 2021

Fast chromatography of AAV – purification and analytics

Fast chromatography of AAV – purification and analytics

Maja Leskovec

20 December 2021

Infographic

Therapeutic potential of extracellular vesicles poster

Therapeutic potential of extracellular vesicles poster

24 January 2022